Nuventra Pharma Sciences to Present at ASCPT Annual Meeting
Nuventra is proud to announce its participation at the American Society for Clinical Pharmacology & Therapeutics (ASCPT) Annual Meeting and Exposition on March 21 – 24, 2018 in Orlando, FL. Nuventra’s scientists…
Read More
Nuventra’s Chief Scientific Officer Elected as 2019-2020 ASCPT President
Nuventra is proud to announce that David Y. Mitchell, Ph.D., Chief Scientific Officer, has been elected as President-Elect of the American Society for Clinical Pharmacology and Therapeutics (ASCPT). Dr. Mitchell…
Read More
Nuventra’s CEO Featured on Spectrum News Show “In Focus with Loretta Boniti”
Geoffrey Banks, Ph.D., Nuventra’s President and CEO, was featured on Spectrum News’ In Focus show which aired on Sunday, December 3. In Focus is a new, 30-minute public affairs program…
Read More
Nuventra Ranked 28th Fastest-Growing Company in the Triangle
On Wednesday, Nov. 8 2017, Nuventra was honored as one of the fastest growing private companies by the Triangle Business Journal (TBJ) at the Fast 50 awards reception. Ranking 28th…
Read More
Nuventra Launches New Website
Durham, NC, November 1, 2017: Nuventra Pharma Sciences is proud to announce the launch of their newly remodeled website, www.nuventra.com. After several months of careful deliberation and content re-organization, the…
Read More
Nuventra’s Chief Scientific Officer to Speak at AAPS 2017 in San Diego, CA
Join Nuventra at the Annual American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition on Nov. 12 – 15 in San Diego, CA. David (Dave) Mitchell, Ph.D., Nuventra’s Chief Scientific Officer…
Read More
Nuventra Pharma Sciences Named a TBJ Fast 50 Award Winner for Second Consecutive Year
Nuventra Pharma Sciences, a specialized drug development consulting company, announces that it has been ranked as a part of the Triangle Business Journal’s Fast 50 List honoring the 50 fastest…
Read More